Profile
John Connelly worked as Vice President-Program & Alliance Management at Voyager Therapeutics, Inc. from 2015 to 2018.
He also worked as Chief Development Officer at Akouos, Inc. Mr. Connelly holds an MBA from Suffolk University and an undergraduate degree from the University of Vermont.
Former positions of John Connelly
| Companies | Position | End |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Corporate Officer/Principal | 2018-01-31 |
| AKOUOS | Corporate Officer/Principal | - |
Training of John Connelly
| University of Vermont | Undergraduate Degree |
| Suffolk University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- John Connelly
